首页> 美国卫生研究院文献>other >Salvage Pancreaticoduodenectomy After Complete Response to Chemoradiotherapy for a Previously Unresectable Pancreatic Adenosquamous Carcinoma
【2h】

Salvage Pancreaticoduodenectomy After Complete Response to Chemoradiotherapy for a Previously Unresectable Pancreatic Adenosquamous Carcinoma

机译:对以前无法切除的胰腺腺鳞癌的放化疗完全缓解后请挽救胰十二指肠切除术

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pancreatic cancer is known for its typically late presentation and poor survival rates, with overall 5-year survival of less than 5%. The role of chemotherapy alone or with radiotherapy in the management of locally advanced tumors continues to be an area of debate.We report a case of locally advanced, pancreatic adenosquamous carcinoma that was initially deemed unresectable intraoperatively. Nonetheless, the tumor was resected after radiological response to gemcitabine-capecitabine chemoradiotherapy regimen similar to the Selective Chemoradiation in Advanced LOcalised Pancreatic cancer trial. Histological examination revealed complete pathological response with extensive fibrosis (ypT0 N0). On 12-month follow-up CT, a single liver lesion in the left lateral segment was identified and confirmed to be a metastasis with cytological diagnosis via EUS and FNA. The disease remained stable and confined to the solitary hepatic metastasis after further gemcitabine chemotherapy. Therefore, a further successful resection was performed.The 2 main strategies for the management of locally advanced unresectable pancreatic cancer are chemotherapy induction followed by consolidation chemoradiotherapy or chemotherapy alone, with conflicting published evidence. Evidence for the optimal management of the rare histological type of adenosquamous carcinoma is scant. We present a case of such tumor with a complete pathological response to chemoradiotherapy. The results of future studies in the area are eagerly awaited.
机译:胰腺癌以其典型的晚期发病和较差的生存率而闻名,其总体5年生存率不到5%。单独化疗或放疗在局部晚期肿瘤管理中的作用仍是一个争论的话题。我们报道了一例局部晚期胰腺腺鳞癌,最初被认为无法在手术中切除。尽管如此,在吉西他滨-卡培他滨化学放疗方案的放射学反应类似于晚期局部胰腺癌试验中的选择性化学放疗后,肿瘤仍被切除。组织学检查显示完全的病理反应,伴有广泛的纤维化(ypT0 N0)。在12个月的随访CT中,发现左侧外侧节段有一个肝脏病变,并通过EUS和FNA进行了细胞学诊断,证实为转移灶。在进一步吉西他滨化疗后,该病保持稳定并仅限于孤立的肝转移。因此,进行了进一步成功的切除。局部晚期不可切除的胰腺癌的2种主要治疗策略是诱导化疗,然后进行巩固放化疗或单独进行化疗,但证据相互矛盾。稀有组织学类型的腺鳞癌的最佳治疗的证据很少。我们介绍了这种肿瘤对放化疗的完全病理反应的情况。迫切期待该地区未来的研究结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号